Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Newegg Commerce Inc (NEGG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Newegg Commerce Inc — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Newegg Commerce Inc trades at $10.79 (market cap $232.74M). The key difference: Maravai LifeSciences Holdings Inc. Class A Common Stock is far larger — about 4.2× Newegg Commerce Inc's market cap, and Maravai LifeSciences Holdings Inc. Class A Common Stock is trading nearer its 52-week high, Newegg Commerce Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Newegg Commerce Inc for 14 Days on average.
| MRVI | NEGG | |
|---|---|---|
Market Cap | $972.90M | $232.74M |
Volume | 4,325,710 | 40,856 |
Sector | Health | Consumer Cyclical |
52-Week High | $9.00 | $92.74 |
52-Week Low | $2.83 | $10.61 |
Typical Hold Time | 0 Days | 14 Days |
Enterprise Value | $1.08B | $202.98M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
NEGG trades at $10.61, down 6.52% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported revenue of $1.44 billion in 2025 with a net loss of $4.88 million, though recent quarters have beaten EPS estimates. Valuation ratios show a low P/S of 0.17 but a P/E of 24.52, while cash flow trends indicate reliance on financing activities. Recent news highlights partnerships with Western Digital and Hewlett Packard Enterprise to support IT infrastructure.
The outlook is mixed: improving profitability and strategic partnerships offer upside, but persistent net losses, negative operating cash flow, and insider selling pose risks. Analyst consensus is Buy with a $7.75 price target, below the current price, suggesting cautious optimism amid operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Newegg Commerce Inc
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products and provides certain third-party logistics services globally.
Read more on NEGG →
